Neuren drug finally been cleared by FDA in USA
SYDNEY: Australia’s top performing health stock for 2022, Neuren, has gained clearance from ... read more
Ebos gets boost with inclusion in prestigious MSCI index
WELLINGTON: Ebos Group, Australasia’s largest distributor of healthcare and medical products, energised the ... read more
Pharmaco expands portfolio with acquisition of Oraltec
AUCKLAND: New Zealand-owned healthcare company Pharmaco (N.Z.) Ltd today announces its continued growth ... read more